Impact of the pink October campaign on breast cancer screening in the Alpes‐Maritimes region (France): A regional perspective
International Journal of Gynecology & Obstetrics · 18.11.2026
DOI: 10.1002/ijgo.71512 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 18.11.2026. Verfasst von Emmanuel Barranger und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Objective
Our objective was to describe monthly variations in breast cancer screening activity during the Pink October campaign and assess whether the observed increase extended beyond the campaign period in the Alpes‐Maritimes region of France.
Methods
We conducted a retrospective observational study of aggregated monthly mammogram counts from January 2022 to December 2024. Data on organized screening (DO) were available for all 3 years, whereas data for individual screening (DP) were available only for 2024. Monthly screening activity during October and November was compared with activity during the remaining months using the statistical methods described below.
Results
Organized screening activity peaked in October in each study year, with reported increases of 31% in 2022, 27% in 2023, and 48% in 2024 relative to the respective annual monthly means. The October–November comparison yielded P ‐values of 0.001 in 2022, 0.049 in 2023, and 0.054 in 2024. The 2024 result did not reach the conventional threshold for statistical significance. Individual screening showed a smaller October increase in 2024 (+10% relative to its annual monthly mean), and the October–November comparison was not statistically significant ( P = 0.178). These findings describe temporal variations in screening activity and do not establish a causal effect of the campaign.
Conclusion
Mammography activity, particularly organized screening, increased during the Pink October period in the Alpes‐Maritimes region. However, the aggregated data cannot establish whether this increase represented additional screening or a redistribution of examinations across the calendar year. Further multicenter studies using longer time series and individual‐level data are needed to assess the campaign's effect on screening participation.
Zitieren
APA
Barranger, E., & Najib, B. (2026). Impact of the pink October campaign on breast cancer screening in the Alpes‐Maritimes region (France): A regional perspective. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.71512
Vancouver
Barranger E, Najib B. Impact of the pink October campaign on breast cancer screening in the Alpes‐Maritimes region (France): A regional perspective. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.71512
BibTeX
@article{Barranger2026,
author = {Barranger, Emmanuel and Najib, Bernard},
title = {Impact of the pink October campaign on breast cancer screening in the Alpes‐Maritimes region (France): A regional perspective},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.71512}
}
EUVIMED